In an era where the world is rapidly being reshaped by the power of data, the pharmaceutical giant Novartis has made a bold move, forming an unconventional partnership with BioAge Labs, a relatively unknown biotech firm based in California. The deal, which could escalate to a staggering $550 million, is not centered around the acquisition […]
